What can we learn about human immunodeficiency virus infection from a study of lymphocytic choriomeningitis virus? (Q41672901)

6 October 2017

1 reference

title

What can we learn about human immunodeficiency virus infection from a study of lymphocytic choriomeningitis virus? (English)

1 reference

lymphocytic choriomeningitis

6 October 2017

0 references

1 reference

2

Zinkernagel RM

1 reference

6 October 2017

Klenerman P

1

1 reference

PubMed ID

9416499

6 October 2017

language of work or name

1 reference

1 October 1997

1 reference

6 October 2017

Immunological Reviews

1 reference

6 October 2017

159

1 reference

6 October 2017

5-16

1 reference

Cytotoxic T lymphocytes and viral turnover in HIV type 1 infection

6 October 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01003.X

The completed sequence of lymphocytic choriomeningitis virus reveals a unique RNA structure and a gene for a zinc finger protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01003.X

Organ-specific selection of viral variants during chronic infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01003.X

Genetic basis of viral persistence: single amino acid change in the viral glycoprotein affects ability of lymphocytic choriomeningitis virus to persist in adult mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01003.X

Infection of lymphocytes by a virus that aborts cytotoxic T lymphocyte activity and establishes persistent infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01003.X

The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01003.X

Transmission of human immunodeficiency virus type 1 (HIV-1) from mother to child correlates with viral phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01003.X

Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01003.X

AIDS: decline and fall of immune surveillance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01003.X

Viral dynamics in human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01003.X

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01003.X

Antiviral protection by virus-immune cytotoxic T cells: infected target cells are lysed before infectious virus progeny is assembled

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01003.X

Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01003.X

The fidelity of the reverse transcriptases of human immunodeficiency viruses and murine leukemia virus, exhibited by the mispair extension frequencies, is sequence dependent and enzyme related

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01003.X

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01003.X

The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01003.X

Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01003.X

H-2 compatability requirement for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus. Different cytotoxic T-cell specificities are associated with structures coded for in H-2K or H-2D;

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01003.X

Susceptibility to lymphocytic choriomeningitis virus isolates correlates directly with early and high cytotoxic T cell activity, as well as with footpad swelling reaction, and all three are regulated by H-2D

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01003.X

Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01003.X

Antivirally protective cytotoxic T cell memory to lymphocytic choriomeningitis virus is governed by persisting antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01003.X

The immunology of primary HIV infection: which immune responses control HIV replication?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01003.X

Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01003.X

Large clonal expansions of CD8+ T cells in acute infectious mononucleosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01003.X

The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01003.X

Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with p17 and p24 specificities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01003.X

Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01003.X

Phenotypic analysis of antigen-specific T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01003.X

Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01003.X

Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01003.X

A critical role for neutralizing-antibody-producing B cells, CD4(+) T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01003.X

Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01003.X

Antigenic oscillations and shifting immunodominance in HIV-1 infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01003.X

Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01003.X

T cell receptor antagonists and partial agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01003.X

Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01003.X

21 January 2018

Games that viruses play

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01003.X

Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01003.X

Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01003.X

Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01003.X

Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01003.X

Studies in subjects with long-term nonprogressive human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01003.X

Virus-triggered immune suppression in mice caused by virus-specific cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01003.X

Specific cytotoxic T cells eliminate B cells producing virus-neutralizing antibodies [corrected]

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01003.X

Immunosuppression in mice by lymphocytic choriomeningitis virus infection: time dependence during primary and absence of effects on secondary antibody responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01003.X

T cell-mediated hepatitis in mice infected with lymphocytic choriomeningitis virus. Liver cell destruction by H-2 class I-restricted virus-specific cytotoxic T cells as a physiological correlate of the 51Cr-release assay?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01003.X

T cells causing immunological disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01003.X

T-cell-mediated immunopathology versus direct cytolysis by virus: implications for HIV and AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01003.X

Are HIV-specific CTL responses salutary or pathogenic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01003.X

Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01003.X

Susceptibility to murine lymphocytic choriomeningitis maps to class I MHC genes—a model for MHC/disease associations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01003.X

Frequent infection of peripheral blood CD8-positive T-lymphocytes with HIV-1. Edinburgh Heterosexual Transmission Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01003.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01003.X

Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1997.TB01003.X

Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells

21 January 2018

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1126/SCIENCE.270.5243.1811

Identifiers

DOI

10.1111/J.1600-065X.1997.TB01003.X

1 reference

6 October 2017

1 reference

PubMed ID

9416499